Clinical Trial Update: Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating azacitidine combined with chidamide for newly diagnosed peripheral T-cell lymphoma patients unfit for conventional chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Chidamide (chidamide)

Snippet

Sponsor: Ruijin Hospital | Conditions: Peripheral T-cell Lymphoma | Phase 2 | Status: UNKNOWN